Trial · NCT07912866
Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women
NCT07912866, Not applicable, Completed, Quaid-e-Azam Medical College
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women. Trials, record NCT07912866. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912866
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women
- NCT number
- NCT07912866
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 108 participants, actual
- Lead sponsor
- Quaid-e-Azam Medical College
- Conditions
- Pre-eclampsia
- Interventions
- L-Arginine, placebo
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants Who Remained Free of Preeclampsia Until Delivery | From enrollment at 20 weeks of gestation until delivery, | Efficacy was measured as the percentage of participants in each study group who did not develop preeclampsia before delivery. According to the synopsis, preeclampsia was defined as new-onset systolic blood pressure \>140 mmHg and diastolic blood pressure \>90 mmHg, together with urinary protein excretion \>300 mg over 24 hours, after 20 weeks of gestation in previously normotensive women. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912866
GET https://conductscience.org/api/trials/v1/NCT07912866/registered